Jason E. Tester serves as Executive at Tarsus Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jason E. Tester has executed 7 insider transactions totaling $2.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 20, 2020 involved exercising options for 71,427 shares valued at $0.
Jason E. Tester currently holds 1,752,183 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason E. Tester has been a net buyer of TARS stock. They have purchased $2.8M and sold $0 worth of shares.
Jason E. Tester's most recent insider trade was on Oct 20, 2020, when they sold 71,427 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $16.00 |
| Discretionary |
| Oct 20, 2020 | TARS | $0 | Conversion | 245,966 | $N/A | Discretionary |
| Oct 20, 2020 | TARS | $0 | Conversion | 1,434,790 | $N/A | Discretionary |
| Oct 20, 2020 | TARS | $50.0K | Purchase | 3,125 | $16.00 | Discretionary |
| Oct 20, 2020 | TARS | $0 | Conversion | 3,698 | $N/A | Discretionary |
| Oct 20, 2020 | TARS | $0 | Conversion | 21,575 | $N/A | Discretionary |